From Random Acts of AI to Repeatable Content Workflows: How Pharma Marketing Teams Can Use eVa AI

From Random Acts of AI to Repeatable Content Workflows: How Pharma Marketing Teams Can Use eVa AI
PUBLISHED
November 10, 2026

Company size

Enterprise

Market location

Global: EU and local affiliates

Industry

Pharmaceuticals / Life Sciences Marketing

Services provided

Guided AI Pilot, eVa AI Integration into eWizard, DAM Connection, Scoping and Feedback Sessions, AI Compliance Setup

Most pharma marketing teams already have generative AI. Far fewer can rely on it. Marketers don’t know which tasks they can hand off, when a person needs to review the output, or whether AI can safely reuse content that’s already approved. So they keep writing from scratch.

This use case shows how a guided eVa AI pilot closes that gap. The AI works inside the eWizard workflows teams already use, and humans still make the decisions.

Drafts built from approved content, not a blank prompt. eVa AI pulls approved claims, images and templates from your DAM to turn a brief into a first draft that’s ready for review.
No more black box. Every claim links back to its source passage. AI-generated visuals carry a visible watermark and a machine-readable marking that follow the EU AI Act.
Reuse and localization in one place. Marketers can adapt assets that are almost right, return to earlier AI conversations, and translate text inside images without rebuilding the visual.

Many brands use most of their content only once, even after paying for agency work, medical review and localization. See how a guided pilot makes reusing it a habit.

    • No countries found

    By submitting this form, I hereby consent to the given personal data being used by Viseven to send me information materials defined in the Privacy Policy, which I have read and agree. I understand that I can change my communication preferences anytime.